Sphingolipids Mediate Differential Echinocandin Susceptibility in Candida Albicans and Aspergillus Nidulans

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.04667-14
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Pyrosequencing to Detect Mutations in FKS1 That Confer Reduced Echinocandin Susceptibility in Candida Albicans

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2008English

Changes in the Proteome of Candida Albicans in Response to Azole, Polyene, and Echinocandin Antifungal Agents

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2010English

Susceptibility Testing of Candida Albicans and Candida Glabrata to Glycyrrhiza Glabra L.

Industrial Crops and Products
AgronomyCrop Science
2017English

Differential Dendritic Cell Responses to Cell Wall Mannan of Candida Albicans, Candida Parapsilosis, and Candida Dubliniensis

Journal of oral science
MedicineDentistry
2018English

Candida Albicans

Current Biology
GeneticsMolecular BiologyBiochemistryBiological SciencesNeuroscienceAgricultural
2012English

Ergosterol and Lanosterol From Aspergillus Nidulans

Microbiology
Microbiology
1982English

Genome-Wide Expression Profiling of the Response to Azole, Polyene, Echinocandin, and Pyrimidine Antifungal Agents in Candida Albicans

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2005English

CFTR and Sphingolipids Mediate Hypoxic Pulmonary Vasoconstriction

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2015English

Serologic IgE Immune Responses Against Aspergillus Fumigatus and Candida Albicans in Patients With Cystic Fibrosis

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy